Association Between Cardiometabolic Comorbidity Burden and Outcomes in Heart Failure
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.036985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Carine E Hamo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Leon H. Charney Division of Cardiology, Department of Medicine New York University School of Medicine New York NY. Hauptthemen laut MEDLINE: Heart Failure, Obesity, Hypertension, Diabetes Mellitus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Cardiometabolic comorbidities such as obesity, diabetes, and hypertension are highly prevalent in heart failure (HF). We aimed to examine the association between severity of cardiometabolic comorbidities and hospitalization in patients with HF.
Methods
In a retrospective electronic health record‐based cohort of adults ≥ $$ \ge $$ 18 with HF, we categorized individuals based on the number of severe cardiometabolic comorbidities, including hypertension, diabetes, and obesity. Severely uncontrolled comorbidities were defined as systolic blood pressure ≥160 mm Hg, hemoglobin A1c ≥8%, and body mass index ≥35 kg/m 2 . Cox regression models were used to assess the association between cardiometabolic comorbidity burden and time to all‐cause and HF hospitalization at 1 year, adjusting for age, sex, race or ethnicity, and insurance status, smoking, prior hospitalization, and Elixhauser comorbidity index. Stratified analyses were conducted for HF with preserved and reduced ejection fraction.
Results
A total of 26 800 individuals with HF (mean age 75 ± $$ \pm $$ 13.7, 46% women, 69% White) experienced 4284 (16%) hospitalizations over a 1‐year period. Compared with individuals with absent comorbidities, those with 1 or 2 to 3 severely uncontrolled comorbidities had a significantly higher risk of all‐cause hospitalization (hazard ratio [HR], 1.23 [95% CI, 1.09–1.39] and HR, 1.57 [95% CI, 1.35–1.83], respectively). We found similar associations for HF hospitalization. These associations were similar among individuals with HF with preserved ejection fraction compared with HF with reduced ejection fraction.
Conclusions
Greater cardiometabolic comorbidity burden was associated with increased risk of all‐cause hospitalization in HF. This reinforces the role for targeting severely uncontrolled cardiometabolic comorbidities to reduce morbidity in HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leon H. Charney Division of Cardiology, Department of Medicine New York University School of Medicine New York NY.
- Department of Population Health New York University Grossman School of Medicine New York NY.
- Division of Cardiology Johns Hopkins University Baltimore MD.
ORCID-Profile: Carine E Hamo, Xiyue Li, Chiadi E Ndumele, Amrita Mukhopadhyay, Samrachana Adhikari, Saul Blecker
Förderung
- NHLBI NIH HHS
Zitieren
APA
Hamo, C. E., Li, X., Ndumele, C. E., Mukhopadhyay, A., Adhikari, S., & Blecker, S. (2025). Association Between Cardiometabolic Comorbidity Burden and Outcomes in Heart Failure. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036985
Vancouver
Hamo CE, Li X, Ndumele CE, Mukhopadhyay A, Adhikari S, Blecker S. Association Between Cardiometabolic Comorbidity Burden and Outcomes in Heart Failure. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.036985
BibTeX
@article{Hamo2025,
author = {Hamo, Carine E and Li, Xiyue and Ndumele, Chiadi E and Mukhopadhyay, Amrita and Adhikari, Samrachana and Blecker, Saul},
title = {Association Between Cardiometabolic Comorbidity Burden and Outcomes in Heart Failure},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.036985}
}
EUVIMED